The aim of this cohort study is to collect prospectively clinical data on all the patients admitted in the investigators department for bariatric surgery or for any complication of a bariatric procedure. The investigators goal is not only to improve the follow-up but also to assess and publish the investigators results regarding weight loss and the complication rate.
Study Type
OBSERVATIONAL
Enrollment
5,000
gastric bypass Or gastric banding Or Biliopancreatic diversion with duodenal switch Or sleeve gastrectomy Or endoscopic procedure (Endobarrier,…)
Department of Digestive Surgery, University Hospital of Edouard Herriot, Hospices Civils de Lyon
Lyon, France
RECRUITINGWeight loss in kg
Time frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Weight loss in kg/m²
Time frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
Excess Weight Loss
Time frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
% weight loss
Time frame: Before surgery (Day 0) and After surgery (every year, up to 25 years or loss to follow-up)
type of surgical procedure
gastric bypass, sleeve gastrectomy, gastric banding, biliopancreatic diversion, redo surgery, endoscopic procedure…
Time frame: at the time of surgery (Day 1)
age
demographic data: age
Time frame: before surgery (Day 0)
gender
demographic data: gender
Time frame: before surgery (Day 0)
Type of comorbidities
demographic data: comorbidities (diabetes, arterial hypertension, sleep apnea, dyslipidemia)
Time frame: before surgery (Day 0)
surgical complications
leaks, hemorrhage, phlebitis, pulmonary embolism, nutritional deficiencies, occlusions,…
Time frame: per and postoperative (up to 25 years or loss to follow-up)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
dose of insulin
evolution of comorbidities: evolution of medical treatment
Time frame: after surgery (up to 25 years or loss to follow-up)
number of oral medications
evolution of comorbidities: evolution of medical treatment
Time frame: after surgery (up to 25 years or loss to follow-up)